
RAPID COMMUNICATION
Phase I and Clinical Pharmacology
Article Tools

OPTIONS & TOOLS
COMPANION ARTICLES
No companion articles
ARTICLE CITATION
DOI: 10.1200/JCO.23.00434 Journal of Clinical Oncology - published online before print April 26, 2023
PMID: 37099736
Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation
Tanios S. Bekaii-Saab
, MD1; Rona Yaeger
, MD2; Alexander I. Spira
, MD3,4,5; Meredith S. Pelster
, MD6; Joshua K. Sabari
, MD7; Navid Hafez
, MD8; Minal Barve, MD9; Karen Velastegui, BSc10; Xiaohong Yan
, PhD10; Aditya Shetty, MD10; Hirak Der-Torossian
, MD10; and Shubham Pant, MBBS11 Show More
1Department of Medical Oncology and Hematology, Mayo Clinic, Scottsdale, AZ
2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Virginia Cancer Specialists, Fairfax, VA
4NEXT Oncology, Fairfax, VA
5US Oncology Research, The Woodlands, TX
6Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN
7Perlmutter Cancer Center, New York University Langone Health, New York, NY
8Yale Cancer Center, New Haven, CT
9Mary Crowley Cancer Research, Dallas, TX
10Mirati Therapeutics, Inc, San Diego, CA
11The University of Texas MD Anderson Cancer Center, Houston, TX








2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Virginia Cancer Specialists, Fairfax, VA
4NEXT Oncology, Fairfax, VA
5US Oncology Research, The Woodlands, TX
6Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN
7Perlmutter Cancer Center, New York University Langone Health, New York, NY
8Yale Cancer Center, New Haven, CT
9Mary Crowley Cancer Research, Dallas, TX
10Mirati Therapeutics, Inc, San Diego, CA
11The University of Texas MD Anderson Cancer Center, Houston, TX
Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/